These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A selective Na Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140 [TBL] [Abstract][Full Text] [Related]
4. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome. Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343 [TBL] [Abstract][Full Text] [Related]
5. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome. Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316 [TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model. Yuan Y; Lopez-Santiago L; Denomme N; Chen C; O'Malley HA; Hodges SL; Ji S; Han Z; Christiansen A; Isom LL Brain; 2024 Apr; 147(4):1231-1246. PubMed ID: 37812817 [TBL] [Abstract][Full Text] [Related]
7. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome. Dyment DA; Schock SC; Deloughery K; Tran MH; Ure K; Nutter LMJ; Creighton A; Yuan J; Banderali U; Comas T; Baumann E; Jezierski A; ; Boycott KM; Mackenzie AE; Martina M Genetics; 2020 Aug; 215(4):1055-1066. PubMed ID: 32554600 [TBL] [Abstract][Full Text] [Related]
8. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome. Cheah CS; Yu FH; Westenbroek RE; Kalume FK; Oakley JC; Potter GB; Rubenstein JL; Catterall WA Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14646-51. PubMed ID: 22908258 [TBL] [Abstract][Full Text] [Related]
9. Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome. Almog Y; Fadila S; Brusel M; Mavashov A; Anderson K; Rubinstein M Neurobiol Dis; 2021 Jan; 148():105209. PubMed ID: 33271326 [TBL] [Abstract][Full Text] [Related]
10. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome. Valassina N; Brusco S; Salamone A; Serra L; Luoni M; Giannelli S; Bido S; Massimino L; Ungaro F; Mazzara PG; D'Adamo P; Lignani G; Broccoli V; Colasante G Nat Commun; 2022 Jan; 13(1):161. PubMed ID: 35013317 [TBL] [Abstract][Full Text] [Related]
11. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome. Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701 [TBL] [Abstract][Full Text] [Related]
12. Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome. Ogiwara I; Iwasato T; Miyamoto H; Iwata R; Yamagata T; Mazaki E; Yanagawa Y; Tamamaki N; Hensch TK; Itohara S; Yamakawa K Hum Mol Genet; 2013 Dec; 22(23):4784-804. PubMed ID: 23922229 [TBL] [Abstract][Full Text] [Related]
13. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome. Tai C; Abe Y; Westenbroek RE; Scheuer T; Catterall WA Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3139-48. PubMed ID: 25024183 [TBL] [Abstract][Full Text] [Related]
14. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq. Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696 [TBL] [Abstract][Full Text] [Related]
15. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development. Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421 [TBL] [Abstract][Full Text] [Related]
16. Dissecting the phenotypes of Dravet syndrome by gene deletion. Rubinstein M; Han S; Tai C; Westenbroek RE; Hunker A; Scheuer T; Catterall WA Brain; 2015 Aug; 138(Pt 8):2219-33. PubMed ID: 26017580 [TBL] [Abstract][Full Text] [Related]
17. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients. Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE Elife; 2016 Jul; 5():. PubMed ID: 27458797 [TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome. Goff KM; Goldberg EM Elife; 2019 Jul; 8():. PubMed ID: 31282864 [TBL] [Abstract][Full Text] [Related]
20. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome. Gu F; Parada I; Yang T; Longo FM; Prince DA Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35165147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]